Brief: Cytodyn Appoints Scott A. Kelly As Chief Medical Officer And Head Of Business Development
13/04/2020 12:12
April 13 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN APPOINTS SCOTT A. KELLY, M.D., AS CHIEF MEDICAL
OFFICER
AND HEAD OF BUSINESS DEVELOPMENT
Source text for Eikon: ID:nGNX5Mb06M
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer